| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1376914 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages |
A series of novel and potent 3,4-diamino-2,5-thiadiazole-1-oxides were prepared and found to show excellent binding affinities for CXCR2 and CXCR1 receptors and excellent inhibitory activity of Gro-α and IL-8 mediated in vitro hPMN MPO release of CXCR2 and CXCR1 expressing cell lines. On the other hand, a closely related 3,4-diamino-2,5-thiadiazole-dioxide did not show functional activity despite its excellent binding affinities for CXCR2 and CXCR1 in membrane binding assays. A detailed SAR has been discussed in these two closely related structures.
Graphical abstractA novel series of structurally related 3,4-diamino-2,5-thiadiazole-1,1-dioxides and 3,4-diamino-2,5-thiadiazole-1-oxides prepared as CXCR2/CXCR1 receptor antagonists is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
